Skip to main content
Clinical Trials/CTRI/2025/02/079846
CTRI/2025/02/079846
Not yet recruiting
Phase 2

Effectiveness of Customized Interventions on Therapeutic Response and Quality of Life among the Adults with H hypertension attending medicine OPDs of selected hospital in Sikkim A Randomized Controlled Trial

Sikkim Manipal College of Nursing1 site in 1 country550 target enrollmentStarted: March 1, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Sikkim Manipal College of Nursing
Enrollment
550
Locations
1
Primary Endpoint
Serum homocysteine level and Blood pressure

Overview

Brief Summary

The current study is a Randomized Controlled Trial among the adults with H-hypertension attending medicine OPDs of selected hospital in Sikkim. The objectives are to assess the proportion of H-hypertension in phase 1 & in phase 2, to find the effectiveness of customized interventions on therapeutic response among the subjects in experimental group as compared to the control group at baseline, two, four and six months. The primary outcome is to reduce the serum homocysteine level among participants with H-hypertension thereby reducing the blood pressure & the secondary outcome is the controlled blood pressure may contribute towards maintaining the QoL of the participant, the adherence to antihypertensives and dietary practices will be emphasized so that it will also contribute positively towards reduction of homocysteine and control of hypertension and prevent complications leading to CADs, MI, Heart attack, Heart failure, Stroke and CKD.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
19.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Phase 1 550 sample size Age 19-60 years willing to participate in the study Able to read and understand English Nepali language Phase 2 104 sample size Adults diagnosed to have H hypertension in phase 1 The participants will be randomized into experimental and control group 54 each in both group but it will be recalculated after the finding of the phase 1.

Exclusion Criteria

  • Phase 1 Hypertensive adults with comorbidities such as Coronary Artery Disease Myocardial Infarction Heart Failure Heart attack Stroke Diabetes Mellitus Chronic Kidney Disease Physical and or Mental disability Adults who are under folic acid and vitamin B supplementation adults with the report of serum homocysteine level more than 15micromole per liter Phase 2 Adults with Baseline systolic BP 180mmHg and diastolic BP 110mmHg Report of serum homocysteine level more than 15micromole per liter.

Outcomes

Primary Outcomes

Serum homocysteine level and Blood pressure

Time Frame: During enrollment to the study | 2nd month after intervention | 4th month after intervention | 6th month after intervention

Secondary Outcomes

  • Adherence to antihypertensives(Adherence to dietary practices and Quality of Life)

Investigators

Sponsor
Sikkim Manipal College of Nursing
Sponsor Class
Research institution
Responsible Party
Principal Investigator
Principal Investigator

Wangkheimayum Ashalata Devi

Sikkim Manipal College of Nursing Sikkim Manipal University

Study Sites (1)

Loading locations...

Similar Trials